en · de · es
analytical-notes.peptides5388.com › Blog › Analytical Detection And Laboratory Handling — Deep Dive

Analytical Detection And Laboratory Handling — Deep Dive

By Editorial Desk · published 2025-12-03 · last reviewed 2025-12-18 · Blog

A practical reference on HPLC-UV: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-12-18 and is reviewed periodically as new material appears.

Analytical Detection and Laboratory Handling

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Background and Pharmacological Mechanism

SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.

SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.

Sr9009 at a glance

PropertyValueNotes
AppearanceOff-white to pale yellow solidVisual description varies with purity and source
SolubilitySoluble in DMSO and ethanol; poorly soluble in waterOrganic stock solutions are common in research
Typical storage-20 °C, desiccated, protected from lightAvoid repeated freeze-thaw cycles
Typical analytical methodLC-MS or HPLC-UVReference standards are needed for quantification
Molar massApproximately 437.9 g/molCalculated from the reported free-base formula

Handling Storage and Quality Control

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Related pages on this site

SR9009 Handling and Quality Control

SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.

Background and Research Status

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

Analytical Detection and Storage

Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Reference notes

L94A1 is the British Ministry of Defence designation for the long-barrelled version of the Hughes EX-34 7.62 mm chain gun, which is fitted to several British Army armoured fighting vehicles, including the Challenger 2 and the Warrior. A second version with a shorter barrel, designated L95A1, was also procured in small numbers. The weapon was produced by Heckler & Koch in the UK.

== Commercial success == Lemonhead candies have been commercially successful since their inception. Lemonheads and other sour candy can also be attributed an increase in growth in non-chocolate confectioners’ sales as opposed to chocolate companies’ sales in the 2015 fiscal year. CEO of Ferrara Candy, Todd Siwak, said, “We are seeing a desire in Millennials for cherry gummy candy, especially with sour, sweet, and intense flavors”.

== Early peptides == The observation that the chemokine CCL2 is potentially responsible for the recruitment of macrophages to atherosclerotic lesions initiated a campaign of research into the a class of molecules that would inhibit the trafficking of leukocytes and act as a new generation of anti-inflammatory agents. ‘Peptide 3’, a dodecapeptide section of CCL2, designed as an allosteric inhibitor of MCP-1 induced leukocyte chemotaxis, was quickly shown by leukocyte migration assay to be a functional inhibitor of many chemokines in vitro with similar potency. The potency of this peptide could be increased by cyclisation and the use of the reverse sequence of D-amino acids. This peptide is called NR58-3.14.3.

Analogues of 2C-T-36 (2C-T-TFM) include 2C-T-21 (2C-T-FE), 2C-T-21.5 (2C-T-DFE), 2C-T-22 (2C-T-TFE), 2C-T-28 (2C-T-FP), 2C-T-35 (2C-T-DFM), 2C-T, 2C-TFM, and 2C-TFE, among others. Some other analogues include 2C-Se-TFM, trifluoromescaline (TFM), 3C-TFE (3C-trifluoroescaline), and tiflorex (flutiorex). A deuterated isotopologue, CYB2108D (2C-T-36 with fully deuterated methoxy groups at 2 and 5 positions), is known.

== Recent recognition == 2019 - Honorary Doctor of Science Degree, Clarkson University 2019 - Herman S. Bloch Award for Scientific Excellence in Industry, University of Chicago 2011 - American Association for Cancer Research Award for Excellence in Chemistry in Cancer Research 2007 - Nobel Laureate Signature Award for Graduate Education in Chemistry, with Anirban Banerjee 2005 - Royal Society of Chemistry Nucleic Acid Award Lecture, Responses to DNA Damage conference

Sources: en.wikipedia.org

Notes from published material

=== Angiogenesis === The formation of new blood vessels is essential for tumor survival and expansion. Intracrines like VEGF and angiogenin regulate angiogenesis within tumor cells and surrounding endothelial cells. Inhibiting intracrine trafficking of angiogenin to the nucleus has been shown to blunt cancer cell proliferation, making this an emerging therapeutic target.

== Plot summary == Reporter and amateur sleuth Joseph Rouletabille is sent to investigate a criminal case at the Château du Glandier and takes along his friend, the lawyer Jean Sainclair, who narrates. Mathilde Stangerson, the 30-something daughter of the castle's owner, Professor Stangerson, was found near-critically battered in a room adjacent to his laboratory on the castle grounds with the door still locked from the inside. She recovers slowly but can give no useful testimony. Rouletabille meets and interrogates several characters: the castle's concierges, Mr and Mrs Bernier; the old servant Jacques; an unfriendly inn landlord; and a womanising gamekeeper, and begins a friendly rivalry with France's top police detective, Frédéric Larsan, who has been assigned the case. Larsan suspects Mlle. Stangerson's fiancé, another scientist called Robert Darzac, to Rouletabille's dismay. More attempts are made on Mlle. Stangerson's life despite Rouletabille and Larsan's protection, and the perpetrator appears to vanish on two occasions when they are closing in on him, echoing Professor Stangerson's research into "matter dissociation". The gamekeeper is murdered during the second attempt. Ultimately, Larsan arrests Darzac who is charged with murder attempts. Rouletabille suspects that Darzac has secret reasons not to defend himself and he disappears to make further investigations.

Cytochrome P-450 is not a single enzyme, but rather consists of a closely related family of 50 isoforms; six of them metabolize 90% of drugs. There is a tremendous diversity of individual P-450 gene products, and this heterogeneity allows the liver to perform oxidation on a vast array of chemicals (including most drugs) in phase 1. Three important characteristics of the P-450 system have roles in drug-induced toxicity:

== Hybrid models == From the beginning, the cyclol reaction was considered as a covalent analog of the hydrogen bond. Therefore, it was natural to consider hybrid models with both types of bonds. This was the subject of Wrinch's fourth paper on the cyclol model (1936), written together with Dorothy Jordan Lloyd, who first proposed that globular proteins are stabilized by hydrogen bonds. A follow-up paper was written in 1937 that referenced other researchers on hydrogen bonding in proteins, such as Maurice Loyal Huggins and Linus Pauling. Wrinch also wrote a paper with William Astbury, noting the possibility of a keto-enol isomerization of the >CαHα and an amide carbonyl group >C=O, producing a crosslink >Cα-C(OHα)< and again converting the oxygen to a hydroxyl group. Such reactions could yield five-membered rings, whereas the classic cyclol hypothesis produces six-membered rings. This keto-enol crosslink hypothesis was not developed much further.

USS Windham Bay delivered Grumman F8F Bearcat fighter aircraft to Saigon on January 26, 1951. On March 2, 1951, the United States Navy transferred USS Agenor (LST 490) to the French Navy in Indochina in accordance with the MAAG-led MAP. Renamed RFS Vulcain (A-656), she was used in Operation Hirondelle in 1953. USS Sitkoh Bay carrier delivered Grumman F8F Bearcat aircraft to Saigon on March 26, 1951. During September 1953, USS Belleau Wood (renamed Bois Belleau) was lent to France and sent to French Indochina to replace the Arromanches. She was used to support delta defenders in the Hạ Long Bay operation in May 1954. In August she joined the Franco-American evacuation operation called "Passage to Freedom". The same month, the United States delivered additional aircraft, again using USS Windham Bay. On April 18, 1954, during the siege of Dien Bien Phu, USS Saipan delivered 25 Korean War AU-1 Corsair aircraft for use by the French Aeronavale in supporting the besieged garrison.

Sources: en.wikipedia.org

Further detail

Manuel Antonio Noriega Moreno ( mahn-WEL NOR-ee-AY-gə; Spanish: [maˈnwel noˈɾjeɣa]; February 11, 1934 – May 29, 2017) was a Panamanian military officer and dictator who was the de facto ruler of Panama from 1983 to 1989. He never officially served as president of Panama, instead ruling as an unelected military dictator through puppet presidents. Amassing a personal fortune through drug trafficking operations by the Panamanian military, Noriega had longstanding ties with American intelligence agencies before the United States invasion of Panama removed him from power. Born in Panama City to a poor pardo family, Noriega studied at the Chorrillos Military School in Lima and at the School of the Americas. He became an officer in the Panamanian army, and rose through the ranks in alliance with Omar Torrijos. In 1968, Torrijos overthrew President Arnulfo Arias in a coup. Noriega became chief of military intelligence in Torrijos's government and, after Torrijos's death in 1981, consolidated power to become Panama's de facto ruler in 1983. Beginning in the 1950s, Noriega worked with U.S. intelligence agencies, and became one of the Central Intelligence Agency's most valued intelligence sources. He also served as a conduit for illicit weapons, military equipment, and cash destined for U.S.-backed forces throughout Latin America. Noriega's relationship with the U.S. deteriorated in the late 1980s after the murder of Hugo Spadafora and the forced resignation of President Nicolás Ardito Barletta.

== See also == Amnesic shellfish poisoning Diarrheal shellfish poisoning Neurotoxic shellfish poisoning Harmful algal blooms (see "toxins") Ciguatera Fugu Cyanotoxin Dinoflagellate ecology and physiology (see "neurotoxins", "red tide", and "phosphate") Red tide crisis in Chiloé

dinucleotide A molecular dimer consisting of exactly two covalently linked nucleotides; or any two nucleotides which are immediately adjacent to each other on the same strand of a longer nucleic acid polymer.

There are 203 possible ways that the exchangeability parameters can be restricted to form sub-models of GTR, ranging from the JC69 and F81 models (where all exchangeability parameters are equal) to the SYM model and the full GTR (or REV) model (where all exchangeability parameters are free). The equilibrium base frequencies are typically treated in two different ways: 1) all

== Research == Schymanski's first research publications were from her undergraduate work when she worked on developing new metal-containing polymers which resulted in three lead author publications. As a graduate student, Schymanski started using information on the fragmentation pattern of organic compounds as a means to expand the identification of unknown compounds. Schymanski applied these novel methods to the identification of unknown organic compounds found in wastewater, and used data collectively gathered by the NORMAN Association to define barriers to the identification of unknown organic compounds in water. Identifying and tracking unknown organic compounds continues to be an avenue of research pursued by Schymanski and she is a co-author on a 2014 textbook describing these methods. In 2012, Schymanski and Steffen Neumann started the Critical Assessment of Small Molecule Identification (CASMI) contest that provided researchers with information about unknown organic compounds and challenged them to use automated computational tools identify the unknown compounds. The Metabolomics Society highlighted the 2012 contest in their newsletter. There have been multiple iterations of the contest, and Schymanski examined the results of the 2016 contest. Schymanski's research focuses on characterizing organic compounds found in wastewater and exposomics, or the science of compounds that people are exposed to over their lifetimes.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 detected?

It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.

What is known about its stability?

The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.

Why does solubility matter?

Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.

What is SR9009?

It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.

Network